Discontinued — last reported Q2 '23
Vulcan Materials Company Acquisitions decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$4.70M to $0.00. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -69.9% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.63B | $4.90M | $148.20M | $39.90M | $339.90M | $1.20M | -$500.00K | -$400.00K | $0.00 | $0.00 | $12.30M | $181.10M | $13.00M | $2.06B | -$4.70M | $9.90M | $3.30M | $5.00M | $0.00 |
| QoQ Change | — | — | -99.7% | >999% | -73.1% | +751.9% | -99.6% | -141.7% | +20.0% | +100.0% | — | — | >999% | -92.8% | >999% | -100.2% | +310.6% | -66.7% | +51.5% | -100.0% |
| YoY Change | — | — | — | — | — | -79.2% | -75.5% | -100.3% | -101.0% | -100.0% | -100.0% | >999% | >999% | — | — | -138.2% | -94.5% | -74.6% | -99.8% | +100.0% |